Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Low-molecular weight heparins possess different effects on lung cancer cells in vitro and on cancer patient survival.

ABSTRACT: The risk factors leading to cancer-associated thromboembolism include the patient’s gender, age, cancer type and stage, comorbidities, and therapies. Low-molecular-weight heparins (LMWH) are administrated for the prophylaxis and/or treatment of cancer and comorbid diseases associated with thrombosis. The effects of LMWH on cancer cells and overall patient survival remain controversial.

ORGANISM(S): Homo sapiens

PROVIDER: GSE242413 | GEO | 2026/03/04

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

A Multicenter, Open-label, Prospective Randomized Controlled Trial to evaluate the Effect of Low-Molecular-Weight Heparin on Prevention of Venous Thromboembolism after Laparoscopic Surgery

Project description:Interventions: For patients allocated to the trial group, a subcutaneous injection of enoxaparin 2000 IU twice daily is administered, in addition to conventional physical prophylaxis. Enoxaparin was started 24-36 hours after surgery and continued until 7th post operative day. For patients allocated to the control group, conventional physical prophylaxis such as elastic stocking and / or intermittent pneumatic compression device is provided for a few days Primary outcome(s): The rate of incidence of all the venous thromboembolism including deep vein thrombosis and pulmonary thromboembolism Study Design: Parallel Randomized

| 2625294 | ecrin-mdr-crc

Single-cell RNA sequencing on the vein wall of female mouse deep vein thrombosis

Project description:Deep vein thrombosis (DVT) is a common clinical problem, but its cellular and molecular mechanisms remain incompletely understood. We performed single-cell RNA sequencing (scRNA-seq) on the vein wall of female C57BL/6J mice. Using the inferior vena cava (IVC) ligation model of DVT, we profiled the cellular heterogeneity and gene expression shifts occurring within the vein wall during the acute phase of thrombosis. This dataset provides a high-resolution map of the vascular response to acute venous thromboembolism.

2026-06-03 | GSE326575 | GEO

Proteomics of lung tissues from COVID19 patients

Project description:Coagulopathy is a hallmark finding in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is associated with an increased risk of death from venous and arterial thromboembolic complications. SARS-CoV-2 infection can lead to microvascular thrombosis that contributes to acute lung injury and respiratory failure. The molecular mechanisms leading to thrombosis in Coronavirus disease 2019 (COVID19) patients are poorly understood. Here, we study a role of the procoagulant neutrophil extracellular traps (NETs)/Factor XII (FXII) axis in COVID19-associated thromboembolism.

2021-08-20 | PXD020216 | Pride

Proteomics of Plasma samples from COVID19 patients

2021-08-20 | PXD020279 | Pride

Gene expression analysis in obsessive-compulsive disorder with and without comorbid neurodevelopmental disorders

Project description:Obsessive-compulsive disorder (OCD) is an intractable disease with a prevalence of 2-3%. Despite treatment with antidepressants, its pathogenesis remains unclear. Recent research suggests immunological mechanisms, particularly in OCD comorbid with neurodevelopmental disorders (NDD) like ASD, ADHD, and TD. This study investigates immune factors involved in OCD and its comorbidities. To reveal the mechanism, RNA-Seq was performed.

2026-03-31 | GSE271268 | GEO

Plasma proteomics improves thrombosis prediction in cancer and implicates a targetable IL-17-driven endothelial activation pathway

Project description:Thrombosis remains a major cause of morbidity and mortality in cancer patients. Existing risk models fail to reliably predict venous thromboembolism (VTE), underscoring the need for more accurate predictive models. In this study, we conducted a high-throughput proteomic analysis of 1,105 plasma proteins from newly diagnosed lung and gastric cancer patients prospectively monitored for VTE development. Utilizing a Bayesian probabilistic machine learning approach, we developed a predictive model incorporating 11 protein biomarkers and five clinical parameters (age, sex, history of VTE, body mass index, and hemoglobin), which significantly outperformed the Khorana prediction model. Orthogonal validation in an external placebo cohort from a phase III trial confirmed the model’s predictive power. Further investigation into the mechanistic role of CD200R1, a checkpoint receptor limiting leukocyte inflammatory response that contributed strongly to the model, showed that reduced levels in plasma correlated with higher D-dimer and thrombosis risk. In CD200R1-deficient mice, elevated thrombin-antithrombin complexes confirmed a prothrombotic state characterized by increased IL-17A and endothelial inflammation. Administration of anti-IL-17A antibodies to CD200R1 deficient mice normalized thrombin generation in vivo, and a meta-analysis of human clinical IL-17A inhibitory antibody studies confirmed antithrombotic activity. These findings improve the prediction of thrombosis in cancer and highlight the utility of plasma proteomics to identify unanticipated mechanistic insights and therapeutic targets in thrombo-inflammatory disease.

2026-03-01 | GSE308452 | GEO

Transcriptomic Analysis of Long Non-coding RNAs and mRNAs in a Mouse Model of Venous Thrombosis

Project description:Recent advancements have identified numerous long non-coding RNAs (lncRNAs) involved in various biological processes and diseases. However, the roles of lncRNAs in venous thromboembolism (VTE) remain largely unexplored. This study aims to elucidate the expression profiles of lncRNAs and mRNAs in a well-established animal model of VTE. Acute thrombosis was induced by surgical ligation of the inferior vena cava (IVC) within 24 hours. The thrombus burden in venous vessels was evaluated using hematoxylin and eosin staining and Masson's trichrome staining. The IVC and associated thrombus were harvested 24 hours post-ligation, and the extracted RNA was subjected to RNA sequencing (RNA-seq) analysis. This study offers a comprehensive overview of the expression profiles of lncRNAs and mRNAs in a murine model of venous thrombosis, providing novel insights into the roles of RNAs in VTE.

2025-02-19 | GSE269352 | GEO

ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

Project description:Overall, only limited evidence exists regarding the clinical benefit of antithrombotic prophylaxis after laparoscopic surgery for cancer. Four studies reported on the incidence of venous thromboembolism (VTE) after laparoscopic surgery for cancer. These studies differ concerning study design, site of cancer, regimens for antithrombotic prophylaxis and reported incidence of VTE. The aim of this multicenter, randomized study is to assess the clinical benefit of extended (4 weeks) compared to short (one week) heparin prophylaxis after laparoscopic surgery for colorectal cancer.

| 2124630 | ecrin-mdr-crc

Transcriptome analysis of CHD8 ko mice

Project description:Autism Spectrum Disorders includes several behavioral phenotypes in addition to other comorbid conditions. One of the strongest comorbidities in Autism is gastrointestinal issues. Gastrointestinal issues are also prevalent in individuals with mutations in CHD8, which is one of the top autism-related genes. However, the relationship between autism related genes, such as CHD8, gastrointestinal function, and autism related behaviors are yet very unclear. In this study our goal is to explore the molecular mechanism and connection between CHD8 KO and gastrointestinal problems.

2021-08-29 | GSE182815 | GEO

Randomized Phase II trial of Enoxiaparin Sodium for the Prevension of Postoperative Venous Thromboembolism after Laparoscopic Colorectal Cancer Surgery (ENVELOPE study)

Project description:Interventions: Enoxaparin group Subcutaneous injection of enoxaparin 2000U twice daily (postoperative day 2 to discharge) Intermittent pneumatic compression (IPC) prophylaxis (after surgery to postoperative day 1) Control group IPC prophylaxis alone (after surgery to postoperative day 1) Primary outcome(s): Incidence of venos thromboembolism until postoperative day 28 Study Design: Parallel Randomized

| 2633931 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data